#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
Jamie Pierson’s Post
More Relevant Posts
-
Vice President (Technical) at Parexel; Regulatory and Technical CMC Consulting for Advanced Therapies and Biologicals
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social
-
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social
-
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social
-
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social
-
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social
-
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social
-
Vice President (Global leader) Integrated Solutions Strategy, DEI Leader, Co-Lead of Global Disability Steering Committee, Professor (hc), Entrepreneur in Residence, GlobalScot, Speaker and Board member.
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social
-
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social
-
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social
-
#asgct2024 is the premier event for gene and cell research! If you missed the annual meeting, read highlights from Chris Learn, Ph.D., for a concise summary of the big news, informed guidance and future indicators. Dive in:
ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future :: Parexel
share.parexel.social